Dechra Pharmaceuticals launches private placement of unsecured notes
Dechra Pharmaceuticals
3,866.00p
08:01 16/01/24
0.00%
0.00p
Drugmaker Dechra Pharmaceuticals has launched a private placement of €50.0m seven-year and €100.0m ten-year new senior unsecured notes.
FTSE 100
8,060.61
15:45 15/11/24
n/a
n/a
FTSE 350
4,453.56
15:45 15/11/24
n/a
n/a
FTSE All-Share
4,411.85
15:45 15/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
-2.70%
-535.19
Dechra said on Thursday that the issue has "similar covenants" to its existing facilities, while the weighted average coupon of the fixed rate notes will equate to 3.8%.
"The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the Group's debt maturity profile," said Dechra.
The FTSE 100-listed firm added that all proceeds from the placement will be used to repay existing debts on its revolving credit facility.
Reporting by Iain Gilbert at Sharecast.com